Latest filing published 13 Jan 2026 for Praxis Precision Medicines, Inc., €210k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +110.8%Entry US$2.03 · Close at T+365 US$4.28
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Megan Sniecinski: trading record in brief
Megan Sniecinski is a declared insider at 2 companies; the most frequent names are Praxis Precision Medicines, Inc. and Biocryst Pharmaceuticals Inc. The record holds 4 filings, for trades running from 18 November 2019 to 12 January 2026.
Purchases make up the whole of the open-market record (1 purchase, €59k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 3 share grants.
Most recently, on 13 January 2026, the filings show a share grant worth €210k in Praxis Precision Medicines, Inc. The clock since the last published purchase (18 November 2019) now reads 2,548 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Megan Sniecinski
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 885 shares@ US$275.74100.0% of flowCommon StockSEC:0001781480-26-000006:0
- 1,087 shares@ US$288.4556.2% of flowCommon StockSEC:0001689548-26-000013:1
- 9,625 shares0Common StockSEC:0001689548-26-000013:0
- 45,000 shares@ US$1.45100.0% of flowCommon StockSEC:0001127602-19-033033:0Canonical exit: 16 Feb 2020 (T+90)
4 of 4 declarations
